Categories
Loading...
Categories
Tatva Chintan Pharma Chem Limited reported its standalone and consolidated unaudited financial results for the half-year ending September 30, 2024. The company experienced a revenue drop to ₹1,747.68 million from ₹1,986.78 million year-over-year, leading to a net loss of ₹15.08 million. The Board approved these results during a meeting on October 25, 2024. A limited review report from the auditors was also issued, confirming compliance with accounting standards. Further details are available on the company’s website.